Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WILLOW TREE aspirin dose and endotoxin response study
2018-004285-34Phase 4Unknown
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Nov 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of aspirin and ticagrelor in acute coronary syndrome (ACS) (5 arms), sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Status: unknown.
02
Drugs
aspirinticagrelor
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on 2018-004285-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004285-34.